chrX-141865490-A-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_138702.1(MAGEC3):c.143A>T(p.Asp48Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000164 in 1,208,678 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 61 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_138702.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAGEC3 | NM_138702.1 | c.143A>T | p.Asp48Val | missense_variant | 2/8 | ENST00000298296.1 | NP_619647.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAGEC3 | ENST00000298296.1 | c.143A>T | p.Asp48Val | missense_variant | 2/8 | 1 | NM_138702.1 | ENSP00000298296.1 |
Frequencies
GnomAD3 genomes AF: 0.0000538 AC: 6AN: 111474Hom.: 0 Cov.: 23 AF XY: 0.0000297 AC XY: 1AN XY: 33644
GnomAD3 exomes AF: 0.0000495 AC: 9AN: 181943Hom.: 0 AF XY: 0.0000602 AC XY: 4AN XY: 66439
GnomAD4 exome AF: 0.000175 AC: 192AN: 1097204Hom.: 0 Cov.: 30 AF XY: 0.000165 AC XY: 60AN XY: 362614
GnomAD4 genome AF: 0.0000538 AC: 6AN: 111474Hom.: 0 Cov.: 23 AF XY: 0.0000297 AC XY: 1AN XY: 33644
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 26, 2022 | The c.143A>T (p.D48V) alteration is located in exon 2 (coding exon 2) of the MAGEC3 gene. This alteration results from a A to T substitution at nucleotide position 143, causing the aspartic acid (D) at amino acid position 48 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at